CAI FY 2013 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$212M+22.1% YoY

Gross Profit

$145M68.4% margin

Operating Income

$101M47.7% margin

Net Income

$64M30.1% margin

EPS (Diluted)

$2.82

Cash Flow

Operating Cash Flow

$124M

Free Cash Flow

-$188M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.3B

Stockholders' Equity

$415M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$212M	$174M	+22.1%
Gross Profit	$145M	$126M	+15.7%
Operating Income	$101M	$91M	+11.9%
Net Income	$64M	$63M	+0.7%